BBA
AST

Braun-Bostich & Associates’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Braun-Bostich & Associates’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3
Closed – – 350
2018
Q4 		$0 Hold
3
– – ﹤0.01% 344
2018
Q3 		$0 Hold
3
– – ﹤0.01% 341
2018
Q2 		$0 Hold
3
– – ﹤0.01% 336
2018
Q1 		$0 Hold
3
– – ﹤0.01% 344
2017
Q4 		$0 Buy
+3
New +$8 ﹤0.01% 314

Braun-Bostich & Associates's AST Position: Q1 2019 in Review

Braun-Bostich & Associates sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 3 shares.

Braun-Bostich & Associates first reported a position in AST in Q4 2017 and held it in 5 quarters. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Braun-Bostich & Associates reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Braun-Bostich & Associates sold 3 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • Braun-Bostich & Associates first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2017 and held it in 5 quarters.
  • Braun-Bostich & Associates's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Braun-Bostich & Associates's 13F filing for Q1 2019, filed 9 May 2019.